Clinical Trial

A Study of V132 in Healthy Older Participants (V132-001)

Not Yet Recruiting Phase 1
View on ClinicalTrials.gov →
Summary
The goal of this study is to learn about the safety and immune response to the V132 vaccine in healthy older adults.
Trial Details
NCT Number NCT07712575
Lead Sponsor Merck Sharp & Dohme LLC
Conditions Healthy
Enrollment 280 participants
Start Date 2026-08-17
Primary Completion 2028-06-21 (estimated)
Study Completion 2028-06-21 (estimated)
Updated on ClinicalTrials.gov 2026-07-17